ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level [clear]
Results 31 - 40 of 78
Presenter(s): Shibani S. Mukerji, MD, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session addresses the question of why patients with COVID-19 have such diverse clinical presentations. The speaker zooms in at the microscopic level to explore the nature and frequency of neurologic sequelae of COVID-19, covering findings observed on neuroimaging and cerebrospinal fluid testing. The session summarizes data from neuropathological studies, discusses new studies on the involvement of the peripheral nervous system, and explores treatment considerations.
Presenter(s): Rebecca J Boersma, MA, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session reviews the emerging evidence of neurological manifestations of COVID-19 and identifies how SLPs can use their unique position to maximize patient outcomes-whether as a member of an interdisciplinary team or as a solo provider. The session strives to increase clinicians' confidence in their abilities to: identify common cognitive-communication symptoms for patients who have recovered from COVID-19, and evaluate and treat with an individualized, patient-centered approach.
Presenter(s): Soumya Venkitakrishnan; Yu-Hsiang Wu; Nicholas P Giuliani
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Individuals with hearing loss experience negative psychosocial consequences such as distress, depression, and loneliness. If they also experience excessive negative emotional responses (i.e., confusion, frustration, anger) or reduced positive emotional responses (i.e., happiness) compared to listeners with normal hearing, they might be unmotivated to approach communication situations. This course describes a study whose purpose was to determine the feasibility of using facial expressions to measure emotional responses.
Presenter(s): Georgia Cambridge; Tracey Taylor; Wayne Wilson; Wendy Arnott
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This course presents a systematic review that aimed to answer the PICO-format clinical research question: For adults with cochlear implants and severe to profound postlingual sensorineural hearing loss, is auditory training effective in improving listening outcomes?
Presenter(s): Kathleen M. Cienkowski, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: There has been a renewed interest in the provision of aural rehabilitation (AR) services as part of patient-centered hearing health care. Aural rehabilitation is a holistic approach to the management of hearing loss that may include patient education, fitting of devices, and auditory training exercises. Although audiologists may recognize the benefits of comprehensive AR, questions may remain about how to measure functional outcomes of these services. This course reviews functional outcome assessments for aural rehabilitation and how to incorporate these measures into everyday practice to enhance patient success.
Presenter(s): Gayla L. Poling, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Hundreds of medications commonly prescribed for anticancer treatments and some infections are known to cause auditory and/or vestibular dysfunction, known as ototoxicity. This course discusses early detection of ototoxicity through increased awareness, leveraging current tools, and clinical practice approaches for serial monitoring, all of which can provide care teams opportunities to identify adverse effects, modify treatment plans to mitigate hearing loss, and utilize individualized interventions. The speaker discusses strategies for preventing or minimizing cochlear damage to preserve quality of life for patients receiving treatment and to reduce the societal burden of hearing loss.
Presenter(s): Dr. O’neil W. Guthrie, MS, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Gene therapy offers the promise to correct inherited forms of hearing loss as well as acquired forms such as noise-induced hearing loss, ototoxicity, and presbycusis. However, there are several barriers that must be overcome before such potential can be realized. This course describes the conceptual framework that governs gene therapy today, reveals how this framework has influenced current progress, and discusses a re-imagining of inner ear gene therapy with the goal of achieving outcomes that are clinically relevant and realistic.
Presenter(s): Vickie L. Tuten, AuD, CCC-A, CPS/A; Kathy E. Gates, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Noise is prevalent in everyday life, and the general population lacks awareness of the risks of hazardous noise exposure and strategies to reduce noise-induced hearing loss. By integrating hearing loss prevention education into patient encounters and taking advantage of outreach/education opportunities, audiologists can help reduce the prevalence of noise-induced hearing loss. This course discusses the why, where, and how of integrating prevention education into your practice.
Presenter(s): Brooke Lang, MA, CCC-SLP; Kyle Mamiya, MS, CCC-SLP
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: SLPs across work settings face challenges associated with adapting their current evaluation and treatment methods to telepractice. This on demand webinar will discuss adaptations and evidence-based practices for using telepractice to effectively assess and treat individuals with neurogenic communication disorders.
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: This journal self-study course highlights the impacts of the COVID-19 pandemic on people with aphasia, patients with cognitive communication impairments, and patient-provider communication. The findings can inform decision-making and assist SLPs in optimizing treatment for communication challenges for patients with COVID-19 as well as those for whom treatment has been altered as a result of the pandemic.
<< 1 2 3 4 5 6 7 8 >>